+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
DNA Diagnostics Market Size, Share and Trends Analysis Report by Technology (PCR-based Diagnostics, NGS DNA Diagnosis, in-Situ Hybridization Diagnostics), Application (Cancer Genetics Tests), and Region 2024-2030- Product Image
DNA Diagnostics Market Size, Share and Trends Analysis Report by Technology (PCR-based Diagnostics, NGS DNA Diagnosis, in-Situ Hybridization Diagnostics), Application (Cancer Genetics Tests), and Region 2024-2030- Product Image
New

DNA Diagnostics Market Size, Share and Trends Analysis Report by Technology (PCR-based Diagnostics, NGS DNA Diagnosis, in-Situ Hybridization Diagnostics), Application (Cancer Genetics Tests), and Region 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • September 2024
  • Region: Global
  • Grand View Research
  • ID: 5876217
Description Jump to:
The global DNA diagnostics market size is expected to reach a value of USD 14.14 billion in 2030 and is projected to grow at a CAGR of 4.51% from 2024 to 2030. The growth of the market is due to advancements in genome sequencing and the development of personalized DNA-level diagnostic applications. In addition, the rising number of government-sponsored patented research initiatives and funded projects are anticipated to further drive demand in the market. For instance, in December 2022, the UK government announced a funding of USD 229.4 (£175) million for the development and creation of advanced genomic research.

The market growth is highly driven by the introduction of novel technologies for genome profiling. Moreover, with the increasing incidence of chronic oncology and infectious diseases that rely on DNA prototyping for treatment and diagnosis through personalized medicine, the demand for DNA diagnostics/testing-based research is anticipated to increase significantly over the forecast period. Furthermore, the increasing demand for DNA diagnostics/testing is driven by the rising demand for prenatal testing, and in-vitro fertilization is expected to provide positive growth prospects to the market. In September 2022, Eurofins Genoma announced the launch of niPGT-A, an embryo-free, non-invasive preimplantation screening test.

DNA diagnostics enables the comprehensive analysis of tumor genomes through techniques such as next-generation sequencing (NGS). NGS allows for the simultaneous sequencing of multiple genes, providing a detailed view of the genetic alterations present in the tumor. By comparing the tumor genome with normal tissue DNA, scientists and clinicians can identify specific mutations, copy number variations, and structural rearrangements unique to the cancer cells. In June 2022, Illumina, a DNA sequencing and array-based technology provider, introduces a research test developed in collaboration with Merck, aimed at unlocking deeper insights into the tumor genome.

Hepatitis C virus (HCV) is a global health concern, affecting millions of people worldwide. Accurate and timely diagnosis of HCV is crucial for effective treatment and prevention of further transmission. In this context, DNA diagnostics has emerged as a powerful tool for detecting and managing HCV infections. In July 2022, Roche introduced a groundbreaking dual antigen and antibody diagnostic test Elecsys HCV Duo, to aid the global efforts in eradicating the hepatitis C virus.

DNA Diagnostics Market Report Highlights

  • The PCR-based diagnostics segment held the largest share of 50.36% in 2023, the dominance of this segment can be attributed to the widespread market usage and the increase in product availability due to the rising number of key players introducing innovative PCR-based diagnostics
  • NGS DNA diagnosis is projected to grow fastest CAGR of 9.65% over the forecast period owing to advancements in high-throughput sequencing technologies that enable comprehensive genetic analyses.
  • Cancer genetics tests segment held the largest share of 29.47% in 2023. DNA sequencing technologies are increasingly utilized to identify and characterize various cancer types and genetic disorders.
  • North America DNA diagnostics market dominated the overall global market and accounted for the 43.20 %revenue share in 2023.

The leading players in the DNA Diagnostics market include:

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Hologic, Inc.
  • Agilent Technologies Inc.
  • Siemens Healthineers AG
  • Danaher Corporation

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Application
1.2.3. Regional Scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. DNA Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. DNA Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. DNA Diagnostics Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. DNA Diagnostics Market: Technology Movement Analysis
4.3. DNA Diagnostics Market by Technology Outlook (USD Billion)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. PCR-based Diagnostics
4.5.1. PCR-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.6. NGS DNA Diagnosis
4.6.1. NGS DNA Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.7. In-Situ Hybridization Diagnostics
4.7.1. In-Situ Hybridization Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.8. Microarrays-based Diagnostics
4.8.1. Microarrays-based Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
4.9. Other Technologies
4.9.1. In Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. DNA Diagnostics Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. DNA Diagnostics Market: Application Movement Analysis
5.3. DNA Diagnostics Market by Application Outlook (USD Billion)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Cancer Genetics Tests
5.5.1. Cancer Genetics Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6. Infectious Diseases DNA Testing
5.6.1. Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6.2. HBV Diagnostic
5.6.2.1. HBV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6.3. TB Diagnostic
5.6.3.1. TB Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6.4. CT/NG Diagnostic
5.6.4.1. CT/NG Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6.5. HPV Diagnostic
5.6.5.1. HPV Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6.6. MRSA Diagnostic
5.6.6.1. MRSA Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.6.7. Others
5.6.7.1. Others Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.7. Newborn Genetic Screening
5.7.1. Newborn Genetic Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.8. Preimplantation & Reproductive Diagnosis
5.8.1. Preimplantation & Reproductive Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.9. Non-Infectious Diseases DNA Testing
5.9.1. Non-Infectious Diseases DNA Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.9.2. Cardiovascular Diseases
5.9.2.1. Cardiovascular Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.9.3. CNS & PNS Related
5.9.3.1. CNS & PNS Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.9.4. Skeletal, Connective, Ectodermal & Dermal DNA Testing
5.9.4.1. Skeletal, Connective, Ectodermal & Dermal DNA Testing Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.9.5. Lung, Kidney, Liver & GT Related
5.9.5.1. Lung, Kidney, Liver & GT Related Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.9.6. Sensory Diseases
5.9.6.1. Sensory Diseases Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.10. Prenatal DNA Carrier Screening
5.10.1. Prenatal DNA Carrier Screening Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.11. Pharmacogenomics/Drug Metabolism
5.11.1. Pharmacogenomics/Drug Metabolism Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.12. Hematology & Immunology/Identity Diagnostics & Forensics
5.12.1. Hematology & Immunology/Identity Diagnostics & Forensics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
5.13. Others
5.13.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. DNA Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional DNA Diagnostics Market movement analysis
6.3. DNA Diagnostics Market: Regional Estimates & Trend Analysis by Technology, Biomaterial & End-use
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. North America
6.5.1. North America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.2. U.S.
6.5.2.1. U.S. DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.2.2. Key Country Dynamics
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Scenario
6.5.2.5. Competitive Scenario
6.5.3. Canada
6.5.3.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.3.2. Key Country Dynamics
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Scenario
6.5.3.5. Competitive Scenario
6.5.4. Mexico
6.5.4.1. Canada DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.5.4.2. Key Country Dynamics
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Scenario
6.5.4.5. Competitive Scenario
6.6. Europe
6.6.1. Europe DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.2. UK
6.6.2.1. UK DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.2.2. Key Country Dynamics
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Scenario
6.6.2.5. Competitive Scenario
6.6.3. Germany
6.6.3.1. Germany DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.3.2. Key Country Dynamics
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Scenario
6.6.3.5. Competitive Scenario
6.6.4. France
6.6.4.1. France DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.4.2. Key Country Dynamics
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Scenario
6.6.4.5. Competitive Scenario
6.6.5. Italy
6.6.5.1. Italy DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.5.2. Key Country Dynamics
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Scenario
6.6.5.5. Competitive Scenario
6.6.6. Spain
6.6.6.1. Spain DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.6.2. Key Country Dynamics
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Scenario
6.6.6.5. Competitive Scenario
6.6.7. Denmark
6.6.7.1. Denmark DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.7.2. Key Country Dynamics
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Scenario
6.6.7.5. Competitive Scenario
6.6.8. Norway
6.6.8.1. Norway DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.8.2. Key Country Dynamics
6.6.8.3. Regulatory Framework
6.6.8.4. Reimbursement Scenario
6.6.8.5. Competitive Scenario
6.6.9. Sweden
6.6.9.1. Sweden DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.6.9.2. Key Country Dynamics
6.6.9.3. Regulatory Framework
6.6.9.4. Reimbursement Scenario
6.6.9.5. Competitive Scenario
6.7. Asia Pacific
6.7.1. Asia Pacific DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.7.2. Japan
6.7.2.1. Japan DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.7.2.2. Key Country Dynamics
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Scenario
6.7.2.5. Competitive Scenario
6.7.3. China
6.7.3.1. China DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.7.3.2. Key Country Dynamics
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Scenario
6.7.3.5. Competitive Scenario
6.7.4. India
6.7.4.1. India DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.7.4.2. Key Country Dynamics
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement Scenario
6.7.4.5. Competitive Scenario
6.7.5. South Korea
6.7.5.1. South Korea DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.7.5.2. Key Country Dynamics
6.7.5.3. Regulatory Framework
6.7.5.4. Reimbursement Scenario
6.7.5.5. Competitive Scenario
6.7.6. Australia
6.7.6.1. Australia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.7.6.2. Key Country Dynamics
6.7.6.3. Regulatory Framework
6.7.6.4. Reimbursement Scenario
6.7.6.5. Competitive Scenario
6.7.7. Thailand
6.7.7.1. Thailand DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.7.7.2. Key Country Dynamics
6.7.7.3. Regulatory Framework
6.7.7.4. Reimbursement Scenario
6.7.7.5. Competitive Scenario
6.8. Latin America
6.8.1. Latin America DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.8.2. Brazil
6.8.2.1. Brazil DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.8.2.2. Key Country Dynamics
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Scenario
6.8.2.5. Competitive Scenario
6.8.3. Argentina
6.8.3.1. Argentina DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.8.3.2. Key Country Dynamics
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Scenario
6.8.3.5. Competitive Scenario
6.9. Middle East & Africa
6.9.1. Middle East & Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.9.2. South Africa
6.9.2.1. South Africa DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.9.2.2. Key Country Dynamics
6.9.2.3. Regulatory Framework
6.9.2.4. Reimbursement Scenario
6.9.2.5. Competitive Scenario
6.9.3. Saudi Arabia
6.9.3.1. Saudi Arabia DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.9.3.2. Key Country Dynamics
6.9.3.3. Regulatory Framework
6.9.3.4. Reimbursement Scenario
6.9.3.5. Competitive Scenario
6.9.4. UAE
6.9.4.1. UAE DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.9.4.2. Key Country Dynamics
6.9.4.3. Regulatory Framework
6.9.4.4. Reimbursement Scenario
6.9.4.5. Competitive Scenario
6.9.5. Kuwait
6.9.5.1. Kuwait DNA Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
6.9.5.2. Key Country Dynamics
6.9.5.3. Regulatory Framework
6.9.5.4. Reimbursement Scenario
6.9.5.5. Competitive Scenario
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Company Categorization
7.3. Strategy Mapping
7.3.1. NEW PRODUCT LAUNCH
7.3.2. PARTNERSHIPS
7.3.3. ACQUISITION
7.3.4. COLLABORATION
7.4. Key Company Market Share Analysis, 2023
7.5. Key Company Profiles
7.5.1. Abbott
7.5.1.1. Company overview
7.5.1.2. Financial performance
7.5.1.3. Technology benchmarking
7.5.1.4. Strategic initiatives
7.5.2. F. Hoffmann-La Roche Ltd.
7.5.2.1. Company overview
7.5.2.2. Financial performance
7.5.2.3. Technology benchmarking
7.5.2.4. Strategic initiatives
7.5.3. QIAGEN
7.5.3.1. Company overview
7.5.3.2. Financial performance
7.5.3.3. Technology benchmarking
7.5.3.4. Strategic initiatives
7.5.4. Bio-Rad Laboratories, Inc.
7.5.4.1. Company overview
7.5.4.2. Financial performance
7.5.4.3. Technology benchmarking
7.5.4.4. Strategic initiatives
7.5.5. Thermo Fisher Scientific, Inc.
7.5.5.1. Company overview
7.5.5.2. Financial performance
7.5.5.3. Technology benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Illumina, Inc.
7.5.6.1. Company overview
7.5.6.2. Financial performance
7.5.6.3. Technology benchmarking
7.5.6.4. Strategic initiatives
7.5.7. Hologic, Inc.
7.5.7.1. Company overview
7.5.7.2. Financial performance
7.5.7.3. Technology benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Agilent Technologies Inc.
7.5.8.1. Company overview
7.5.8.2. Financial performance
7.5.8.3. Technology benchmarking
7.5.8.4. Strategic initiatives
7.5.9. Siemens Healthineers AG
7.5.9.1. Company overview
7.5.9.2. Financial performance
7.5.9.3. Technology benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Danaher Corporation
7.5.10.1. Company overview
7.5.10.2. Financial performance
7.5.10.3. Technology benchmarking
7.5.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 4 Global DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 5 North America DNA diagnostics market, by region, 2018 - 2030 (USD Billion)
Table 6 North America DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 7 North America DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 8 U.S. DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 9 U.S. DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 10 Canada DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 11 Canada DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 12 Mexico DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 13 Mexico DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 14 Europe DNA diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 15 Europe DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 16 Europe DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 17 UK DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 18 UK DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 19 Germany DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 20 Germany DNA diagnostics market, by application 2018 - 2030 (USD Billion)
Table 21 France DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 22 France DNA diagnostics market, by application 2018 - 2030 (USD Billion)
Table 23 Italy DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 24 Italy DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 25 Spain DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 26 Spain DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 27 Denmark DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 28 Denmark DNA diagnostics market, by application 2018 - 2030 (USD Billion)
Table 29 Norway DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 30 Norway DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 31 Sweden DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 32 Sweden DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 33 Asia Pacific DNA diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 34 Asia Pacific DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 35 Asia Pacific DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 36 Japan DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 37 Japan DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 38 China DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 39 China DNA diagnostics market, by application 2018 - 2030 (USD Billion)
Table 40 India DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 41 India DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 42 Australia DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 43 Australia DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 44 South Korea DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 45 South Korea DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 46 Thailand DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 47 Thailand DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 48 Latin America DNA diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 49 Latin America DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 50 Latin America DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 51 Brazil DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 52 Brazil DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 53 Argentina DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 54 Argentina DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 55 Middle East & Africa DNA diagnostics market, by country, 2018 - 2030 (USD Billion)
Table 56 Middle East & Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 57 Middle East & Africa DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 58 South Africa DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 59 South Africa DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 60 Saudi Arabia DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 61 Saudi Arabia DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 62 UAE DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 63 UAE DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
Table 64 Kuwait DNA diagnostics market, by technology, 2018 - 2030 (USD Billion)
Table 65 Kuwait DNA diagnostics market, by application, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 DNA diagnostics market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Technology snapshot
Fig. 10 Application snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Parent market value, 2023 (USD Billion)
Fig. 13 Market dynamics
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 DNA diagnostics market: Technology outlook and key takeaways
Fig. 17 DNA diagnostics market: Technology movement analysis
Fig. 18 PCR-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Microarrays-based diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 In-situ hybridization diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 NGS DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Other technologies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 DNA diagnostics market: Application outlook and key takeaways
Fig. 24 DNA diagnostics market: Application movement analysis
Fig. 25 Cancer genetics tests market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 HBV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 TB diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 CT/NG diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 HPV diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 MRSA diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Other infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Newborn genetic screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Preimplantation & reproductive diagnosis market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Non-infectious diseases DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Cardiovascular diseases diagnostic market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 CNS & PNS related market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Skeletal, connective, ectodermal & dermal DNA testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Lung, kidney, liver & GT related market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Sensory diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Prenatal DNA carrier screening market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Pharmacogenomics/drug metabolism market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Hematology & immunology/identity diagnostics & forensics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Other applications market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 DNA diagnostics market revenue, by region, 2023 & 2030 (USD Million)
Fig. 46 Regional marketplace: Key takeaways
Fig. 47 Regional marketplace: Key takeaways
Fig. 48 North America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 U.S. DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Canada DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Key country dynamics
Fig. 54 Mexico DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 UK DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Germany DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 France DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Spain DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Italy DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Denmark DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Sweden DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Key country dynamics
Fig. 71 Norway DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Rest of Europe DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Japan DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 China DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 China regulatory details
Fig. 79 Key country dynamics
Fig. 80 India DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Australia DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 Key country dynamics
Fig. 84 Thailand DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 South Korea DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 South Korean regulations in four hierarchical orders
Fig. 88 Rest of Asia Pacific DNA diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 Brazil DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Argentina DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Rest of Latin America DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 South Africa DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Key country dynamics
Fig. 99 Saudi Arabia DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 100 Key country dynamics
Fig. 101 UAE DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 102 Key country dynamics
Fig. 103 Kuwait DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Rest of MEA DNA diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 105 Key company categorization
Fig. 106 Heat map analysis
Fig. 107 Strategic framework

Companies Mentioned

The leading players in the DNA Diagnostics market include:
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Hologic, Inc.
  • Agilent Technologies Inc.
  • Siemens Healthineers AG
  • Danaher Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedSeptember 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 10.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.14 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Liver Disease Diagnostics Market Size, Share and Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy), Disease (NAFLD, NASH, Fibrosis, Cirrhosis), End-use (Hospitals, Laboratories), and Region 2024-2030 - Product Image

Liver Disease Diagnostics Market Size, Share and Trends Analysis Report by Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy, Biopsy), Disease (NAFLD, NASH, Fibrosis, Cirrhosis), End-use (Hospitals, Laboratories), and Region 2024-2030

  • Report
  • 80 Pages
  • Global
From
Global Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (IVD, LDT), Application (Breast Cancer, Lung Cancer), End-use, Test Type, and Segment Forecasts, 2024-2030 - Product Image

Global Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Consumables, Instruments), Type (IVD, LDT), Application (Breast Cancer, Lung Cancer), End-use, Test Type, and Segment Forecasts, 2024-2030

  • Report
  • 240 Pages
  • Global
From
DNA Diagnostics Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2025-2030 - Product Image

DNA Diagnostics Market by Product Type, Technology, Sample Type, Application, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Global DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Forecast to 2029 - Product Image

Global DNA Diagnostics Market Size, Share & Trends by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Forecast to 2029

  • Report
  • 334 Pages
  • Global
From
DNA Diagnostics Global Market Report 2024 - Product Image

DNA Diagnostics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.